Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Kiromic Biopharma, Inc. (KRBP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-KS-1/A
Revenues  0.00.00.01.4
            Revenue growth    -100.0% 
Cost of goods sold  0.00.00.03.2
Gross profit  0.00.00.0-1.8
            Gross margin     -123.4%
Selling, general and administrative   [+]13.914.12.51.8
Research and development  11.45.11.2 
Other operating expenses     -0.3
EBITDA   [+]-24.8-19.0-3.6-3.1
            EBITDA margin     -217.7%
Depreciation and amortization  0.50.20.10.1
EBIT   [+]-25.3-19.2-3.7-3.2
            EBIT margin     -223.4%
Non-recurring items   [+]0.4   
Interest expense  0.00.00.00.6
Other income (expense), net   [+]0.2   
Pre-tax income  -25.6-19.2-3.7-3.8
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -25.6-19.2-3.7-3.8
            Net margin     -267.8%
   
Basic EPS   [+]($2.24)($4.26)($1.30)($1.33)
Diluted EPS   [+]($2.24)($4.26)($1.30)($1.33)
   
   
Shares outstanding (basic)   [+]11.44.52.92.9
Shares outstanding (diluted)   [+]11.44.52.92.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy